ID   14C12
AC   CVCL_LB96
SY   14 C12
DR   Wikidata; Q54581946
RX   Patent=US7582296;
RX   PubMed=14670927;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Belgian Coordinated Collections of Micro-organisms (BCCM); LMBP 5878CB.
CC   Monoclonal antibody isotype: IgG2a.
CC   Monoclonal antibody target: Anti-idiotypic against monoclonal antibody B02C11.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 22-08-17; Last updated: 21-03-23; Version: 4
//
RX   Patent=US7582296;
RA   Gilles J.-G.G., Saint-Remy J.-M.R., Jacquemin M.G.;
RT   "Anti-idiotypic antibodies against factor VIII inhibitor and uses
RT   thereof.";
RL   Patent number US7582296, 01-Sep-2009.
//
RX   PubMed=14670927; DOI=10.1182/blood-2003-07-2207;
RA   Gilles J.-G.G., Grailly S.C., De Maeyer M., Jacquemin M.G.,
RA   Vander Elst L.P., Saint-Remy J.-M.R.;
RT   "In vivo neutralization of a C2 domain-specific human anti-factor VIII
RT   inhibitor by an anti-idiotypic antibody.";
RL   Blood 103:2617-2623(2004).
//